Cost-effectiveness of palivizumab prophylaxis for respiratory syncytial virus (RSV): A systematic review
Cost-effectiveness of palivizumab prophylaxis for respiratory syncytial virus (RSV): A systematic review
帕利珠单抗预防呼吸道合胞病毒 (RSV) 的成本效益：系统评价
批准号：
400020
负责人：
Mac Stephen
金额：
$0.11万
依托单位：
依托单位国家：
加拿大
项目类别：
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-01-01 至 2020-01-01
关键词：
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Introduction: Palivizumab (PMB) is a preventative therapeutic (prophylaxis) given to infants for respiratory syncytial virus (RSV). However, due to its high drug costs, the value of this intervention is unclear. The objective of this study was to conduct
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Estimating the Economic Value of an Interoperable Real-Time 'Command Centre' (CC) Technology at a Major Acute Care Hospital in Ontario, Canada
-
批准号：449213
-
项目类别：Fellowship Programs
-
资助金额：$7.9万
-
财政年份：2021
-
负责人：Mac Stephen
-
依托单位：
Supporting public health decision-making for Lyme disease: Assessing health outcomes, economic burden and intervention strategies using administrative data and decision-analytic models.
-
批准号：406666
-
项目类别：Miscellaneous Programs
-
资助金额：$0.44万
-
财政年份：2019
-
负责人：Mac Stephen
-
依托单位：
The Cost-effectiveness of Vancomycin-Resistant Enterococcus (VRE) Screening and Isolation in Ontario
-
批准号：382866
-
项目类别：
-
资助金额：$0.11万
-
财政年份：2018
-
负责人：Mac Stephen
-
依托单位：
Cost-Effectiveness Analysis of Novel High-Intensity Outpatient Stroke Rehabilitation Program at the Toronto Rehabilitation Institute in Ontario, Canada
-
批准号：368320
-
项目类别：
-
资助金额：$0.07万
-
财政年份：2017
-
负责人：Mac Stephen
-
依托单位：
Supporting public health decision-making for Lyme disease: Assessing health outcomes, economic burden and intervention strategies using administrative data and decision-analytic models.
-
批准号：387254
-
项目类别：Studentship Programs
-
资助金额：$7.65万
-
财政年份：2017
-
负责人：Mac Stephen
-
依托单位：